non-targeting control gRNA (BRDN0001145598) Citations (1)

Originally described in: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE Nat Biotechnol. 2016 Jan 18. doi: 10.1038/nbt.3437. PubMed Journal

---

Articles Citing non-targeting control gRNA (BRDN0001145598)

Articles
BAP1 deletion abrogates growth and metastasis of murine cutaneous melanoma. Luo X, Xu Y, Li Y, Zhang G, Huang S, Liu X, Ren Z, Liu S, Yu L. Melanoma Res. 2021 Apr 1;31(2):119-129. doi: 10.1097/CMR.0000000000000714. PubMed

If you have published an article using this material, please email us at to have your article added to this page.